Linear growth in pediatric renal transplant recipients receiving sirolimus

Pediatric Transplantation

Volumn 15, Issue 6, 2011, Pages 570-572

  Hymes, Leonard C ^a   Warshaw, Barry L ^a  

^a EMORY UNIVERSITY   (United States)

Author keywords

children; growth; renal transplantation; sirolimus

Indexed keywords

BASILIXIMAB; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RAPAMYCIN; TACROLIMUS;

APHTHOUS ULCER; BODY HEIGHT; CHILD; CHILD GROWTH; DRUG BLOOD LEVEL; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; ERECTILE DYSFUNCTION; FEMALE; GRAFT RECIPIENT; HUMAN; INFANT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LEUKOPENIA; LYMPHEDEMA; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PROPHYLAXIS; PROTEINURIA; REVIEW; SCHOOL CHILD;

ADOLESCENT; BODY SIZE; BONE AND BONES; CHILD; CHILD, PRESCHOOL; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT; KIDNEY TRANSPLANTATION; MALE; MUSCLES; RETROSPECTIVE STUDIES; SIROLIMUS;

EID: 80052078140     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2011.01574.x     Document Type: Review

References (12)

1. Hymes LC, Warshaw BL, Amaral SG, Greenbaum LA,. Tacrolimus withdrawal and conversion to sirolimus at three months post-pediatric renal transplantation. Pediatr Transplant 2008: 12: 773-777.
2. Benfield MR, Bartosh S, Ikle D, et al., A randomized double-blind, placebo controlled trial of steroid withdrawal after pediatric renal transplantation. Am J Transplant 2010: 10: 81-88.
3. McDonald RA, Smith JM, Ho M, et al., Incidence of PTLD in pediatric renal transplant recipients receiving basiliximab, calcineurin inhibitor, sirolimus and steroids. Am J Transplant 2008: 8: 984-989. (Pubitemid 351537758)
4. Hymes LC, Warshaw BL,. Sirolimus in pediatric patients: Results in the first 6 months post-renal transplant. Pediatr Transplant 2005: 9: 520-522. (Pubitemid 41153274)
5. Alvarez-Garcia O, Carbajo-Perez E, Garcia E, et al., Rapamycin retards growth and causes marked alterations in the growth plate of young rats. Pediatr Nephrol 2007: 22: 954-961. (Pubitemid 46881913)
6. Aoki MS, Miyabara EH, Soares AG, Saito ET, Moriscot AS,. mTOR pathway inhibition attenuates skeletal muscle growth induced by stretching. Cell Tissue Res 2006: 324: 149-156. (Pubitemid 43320250)
7. Rangel GA, Ariceta G,. Growth failure associated with sirolimus: Case report. Pediatr Nephrol 2009: 24: 2047-2050.
8. Racusen LC, Solez K, Colvin RB, et al., The Banff 97 working classification of renal allograft pathology. Kidney Int 1999: 55: 713-723. (Pubitemid 29082898)
9. Schwartz GJ, Munoz A, Schneider MF, et al., New equations to estimate GFR in children with CKD. J Am Soc Nephrol 2009: 20: 629-637.
10. Ekberg H, Tedesco-Silva H, Demirbas A, et al., Reduced exposure to calcineurin inhibitors in renal transplantation. N Engl J Med 2007: 357: 2562-2575. (Pubitemid 350294223)
11. Tondolo V, Citterio F, Panocchia N, et al., Gonadal function and immunosuppressive therapy after renal transplantation. Transplant Proc 2005: 37: 1915-1917. (Pubitemid 40790868)
12. Fine RN,. Growth post renal-transplantation in children: Lessons from the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Pediatr Transplant 1997: 1: 85-89. (Pubitemid 127684812)